Literature DB >> 2736622

Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment.

R L Williams1, W Risau, H G Zerwes, H Drexler, A Aguzzi, E F Wagner.   

Abstract

Mouse endothelioma cells expressing the polyoma middle T oncogene induced hemangiomas in a variety of species such as mice, rats, chicks, and quails. In embryos and newborn mice the hemangiomas expanded within 10-18 hr of injection, disrupting the vasculature and causing the death of the animal. In contrast, the hemangiomas formed a stable structure reminiscent of benign human hemangiomas in adult mice within 5 days. Analysis of the cells comprising the hemangioma revealed that over 95% of the endothelial cells were host derived. No induction of host cell proliferation was detected, and no endothelial mitogens were secreted by the endothelioma cells in vitro. The maintenance of the hemangioma appeared to require the continuous presence of endothelioma cells. The results indicate that these endothelioma cells act as a potent stimulating agent in the rapid formation of hemangiomas by recruiting nonproliferating host endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2736622     DOI: 10.1016/0092-8674(89)90343-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  61 in total

Review 1.  Pathogenesis of hemangioma.

Authors:  D A Marchuk
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

3.  The polyomavirus middle T-antigen oncogene activates the Hippo pathway tumor suppressor Lats in a Src-dependent manner.

Authors:  M Shanzer; I Ricardo-Lax; R Keshet; N Reuven; Y Shaul
Journal:  Oncogene       Date:  2014-11-03       Impact factor: 9.867

Review 4.  Angiogenesis and angiogenesis inhibitors in paediatric diseases.

Authors:  L Schweigerer; T Fotsis
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

Review 5.  Application of angiogenesis to clinical dermatology.

Authors:  Levi E Fried; Jack L Arbiser
Journal:  Adv Dermatol       Date:  2008

6.  Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2.

Authors:  Hannes C A Drexler; Matthias Vockel; Christian Polaschegg; Maike Frye; Kevin Peters; Dietmar Vestweber
Journal:  Mol Cell Proteomics       Date:  2019-08-19       Impact factor: 5.911

Review 7.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

8.  VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts.

Authors:  Roman Nawroth; Gregor Poell; Alexander Ranft; Stephan Kloep; Ulrike Samulowitz; Gregor Fachinger; Matthew Golding; David T Shima; Urban Deutsch; Dietmar Vestweber
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

9.  A statin-based inhibitor of lymphocyte function antigen-1 protects against ischemia/reperfusion-induced leukocyte adhesion in the colon.

Authors:  Min Xiu Wan; Rene Schramm; Daniel Klintman; Karl Welzenbach; Gabriele Weitz-Schmidt; Henrik Thorlacius
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

10.  Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.

Authors:  Franck Lebrin; Marie-José Goumans; Leon Jonker; Rita L C Carvalho; Gudrun Valdimarsdottir; Midory Thorikay; Christine Mummery; Helen M Arthur; Peter ten Dijke
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.